HeXun Biosciences Co., Ltd. (TPEX:6986)

Market Cap	3.36B
Revenue (ttm)	286.42M
Net Income (ttm)	147.22M
Shares Out	46.00M
EPS (ttm)	3.20
PE Ratio	22.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,179
Average Volume	68,763
Open	73.40
Previous Close	73.40
Day's Range	72.70 - 73.60
52-Week Range	63.10 - 91.30
Beta	n/a
RSI	41.52
Earnings Date	May 9, 2025

About HeXun Biosciences

HeXun Biosciences Co., Ltd. engages in the research and development of stem cell and treatments in Taiwan. It provides outsourced production services; commissioned development and manufacturing services for various cells and cell derivatives; commissioned inspection; advisory; laboratory information management system; and sterile filling services. The company was founded in 2019 and is based in Taoyuan City, Taiwan.

• Industry: Commercial Physical and Biological Research
• Founded: 2019
• Employees: 45
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6986

Financial Performance

In 2024, HeXun Biosciences's revenue was 286.42 million, an increase of 119.36% compared to the previous year's 130.57 million. Earnings were 147.22 million, an increase of 339.62%.